Skin News and Research

RSS

Bristol-Myers Squibb announces new results of Baraclude (entecavir) resistance monitoring program

Bristol-Myers Squibb Company has announced new results of the Baraclude (entecavir) resistance monitoring program, which found a continued low incidence of resistance in studies of nucleoside-naive chronic hepatitis B patients through four years of treatment.

16 Apr 2007

Gleevec shows great promise in preventing cancer recurrence

Gleevec, a pill developed in conjunction with the Oregon Health & Science University Cancer Institute is again showing excellent results in preventing a cancer recurrence.

15 Apr 2007

GlaxoSmithKline initiates study of PROMACTA in chronic idiopathic thrombocytopenic purpura

GlaxoSmithKline has announced the initiation of a global, open-label, single group trial that will assess the efficacy, safety and tolerability of PROMACTA (eltrombopag olamine) in patients previously treated for chronic idiopathic thrombocytopenic purpura (ITP).

15 Apr 2007

Genmab starts HuMax-EGFr combination study

Genmab A/S has announced it has initiated a Phase II study of HuMax-EGFr (zalutumumab) in combination with chemo-radiation to treat non small cell lung cancer (NSCLC).

15 Apr 2007

Doctors identify hot flashes in males

A new study in Psychophysiology confirms a surprising fact?, men who have undergone chemical castration for conditions such as prostate cancer experience hot flashes similar to those experienced by menopausal women.

15 Apr 2007

Bacteria can barge inside immune cells

Immune cells that are the body's front-line defense don't necessarily rest quietly until invading bacteria lock onto receptors on their outside skins and rouse them to action, as previously thought. In a new paper, University of Michigan scientists describe their findings that bacteria can barge inside these guard cells and independently initiate a powerful immune response.

14 Apr 2007

FDA approves GlaxoSmithKline's antibacterial Altabax

GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has approved its antibacterial Altabax for the topical treatment of impetigo due to susceptible strains of Staphylococcus aureus or Streptococcus pyogenes, the two most common types of bacteria in this kind of infection.

14 Apr 2007

FDA approves Altabax ointment for impetigo

The Food and Drug Administration (FDA) approved Altabax (retapamulin ointment) for topical treatment of impetigo, a skin infection caused by bacteria.

14 Apr 2007

Common antiwrinkle product compound causes reaction in skin cells

Researchers from Universit, Laval's Faculty of Medicine have discovered that a compound commonly used in many antiwrinkle products causes a pathological reaction in skin cells.

12 Apr 2007

Study suggests reason for high incidence of cancer in the prostate

Cancer occurs more frequently in the prostates of men than in any organ other than the skin. While DNA damage caused by exposure to the sun is likely the cause of many skin cancers, the cause of prostate cancer remains largely unknown.

12 Apr 2007

Vitiligo gene linked to other autoimmune diseases

In a study appearing in the March 22 New England Journal of Medicine, scientists supported by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) have discovered a connection between a specific gene and the inflammatory skin condition vitiligo, as well as a possible host of autoimmune diseases.

11 Apr 2007

American Heart Association highlights BAD fats and BETTER fats

As the nation moves to significantly reduce trans fat consumption, the American Heart Association is launching "Face The Fats," an educational campaign to teach consumers how to minimize trans fat in their diet, while avoiding the unintended health consequence of defaulting to more saturated fat.

11 Apr 2007

Abbott opens biotech facility in Puerto Rico

"This new facility is a key milestone for Abbott as we move to focus our resources and future growth on biologic and potent-drug manufacturing," said Lawrence Kraus, vice president of manufacturing, global pharmaceutical operations, Abbott.

11 Apr 2007

Sunburnt holiday-makers boost their chances of fatal skin cancer

One third of young British holiday-makers will double their chances of developing the most fatal form of skin cancer this summer because they plan to get burnt on the beach.

11 Apr 2007

Development of magnetic cationic liposomes for targeting tumor microvasculature

A popular way to attack malignant tumors is using cationic liposomes as drug delivery systems.

10 Apr 2007

Arsenic-based additive used in chicken feed may pose health risks to humans

Pets may not be the only organisms endangered by some food additives.

10 Apr 2007

Mediterranean diet for children means fewer allergic symptoms

The benefits of a Mediterranean diet have been further enhanced with the latest research by scientists from Greece, Spain and the United Kingdom.

8 Apr 2007

FDA warns consumers on health risks of keeping pet turtles

The Food and Drug Administration (FDA) is urgently reminding the public that contact with baby turtles can pose a serious health risk to infants, small children, and adults with impaired immune systems as they can be natural hosts to Salmonella, a group of bacteria that can cause severe illness and death.

8 Apr 2007

Tai chi helps seniors avoid shingles

According to recent research the ancient Chinese martial art of Tai chi offers benefits beyond improving fitness and balance for older adults.

8 Apr 2007

Mediterranean diet protects against allergic rhinitis and asthma

A "Mediterranean" diet rich in fruits, vegetables and nuts protects against allergic rhinitis and asthma symptoms, suggests research published ahead of print in Thorax.

5 Apr 2007